Physician profile
George A Heberton
NPI 1104265198
$31,801.77
in general payments reported to CMS, 2019-2025
34 companies · $2,238 in 2025
The $2,238 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,361 · 2020: $3,579 · 2021: $5,913 · 2022: $8,065 · 2023: $1,764 · 2024: $6,882 · 2025: $2,238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,159 · Travel and Lodging: $4,316 · Consulting Fee: $400 · Education: $9.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,158.54 |
| Travel and Lodging | $4,315.90 |
| Consulting Fee | $400.00 |
| Education | $9.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $10,914.00 | 2019-2025 | Ensite, Aveir, Ensite Precision |
| Medtronic, INC. | $6,248.75 | 2021-2025 | Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan, Micra |
| Boston Scientific Corporation | $5,354.14 | 2019-2025 | Farapulse, Watchman Access System, Rhythmia Mapping System |
| Biosense Webster, INC. | $2,654.88 | 2019-2025 | Carto 3, Qdot Micro Catheter, Smartablate |
| Medtronic Vascular, INC. | $1,548.63 | 2019-2020 | |
| Medical Device Business Services, INC. | $1,538.63 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $385.69 | 2019-2025 | Camzyos |
| Actelion Pharmaceuticals US, INC. | $358.51 | 2019-2022 | |
| Astellas Pharma US INC | $342.96 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $303.95 | 2019-2023 | Xarelto |
| Amgen INC. | $272.77 | 2019-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $213.21 | 2021-2025 | Lifevest |
| Biotronik INC. | $201.24 | 2019 | |
| Novartis Pharmaceuticals Corporation | $199.60 | 2019-2020 | |
| Philips North America LLC | $195.24 | 2019-2025 | (Ck4) Mcot, Extended Holter, (Ck7) Extended Holter |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $192.32 | 2019-2023 | Farxiga |
| Atricure, INC. | $158.63 | 2021 | |
| Pfizer INC. | $142.23 | 2019-2023 | |
| Cardiva Medical, INC. | $132.62 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Chiesi USA, INC. | $76.25 | 2020-2022 | |
| Abiomed | $58.84 | 2019 | |
| Edwards Lifesciences Corporation | $47.43 | 2024 | |
| Sanofi-Aventis U.S. LLC | $36.32 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $31.86 | 2023 | Verquvo |
| Ethicon US, LLC | $23.47 | 2024 | Vistaseal |
| Genzyme Corporation | $22.80 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $21.75 | 2023 | Arcalyst |
| Portola Pharmaceuticals, LLC | $21.41 | 2020 | |
| W. L. Gore & Associates, INC. | $20.46 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $19.48 | 2024 | Arcalyst |
| Novo Nordisk INC | $17.49 | 2024 | Ozempic |
| Scpharmaceuticals INC. | $15.95 | 2023 | |
| Heartflow, INC. | $15.73 | 2019 | |
| Altathera Pharmaceuticals LLC | $14.53 | 2025 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Heberton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.